Shingles and Shingles Vaccine: An Update Shingles and Shingles Vaccine: An Update
A recently approved shingles vaccine seems to be more effective in preventing the virus. Drs Rapuano and Meghpara from Wills Eye Hospital discuss its role for patients.Wills Eye Hospital
With demand for the newer shingles vaccine, known as Shingrix, far outstripping the pace at which the manufacturer can supply it, shortages will likely continue throughout 2019, predicts the CDC. “GlaxoSmithKline [GSK] are running their vaccine plants as much as they can, to produce more but it’s just not enough,” says Julio Viola, PharmD, the director of centralized pharmacy services at Northwell Health Systems, which operate in the New York metro area.
(Duke University Medical Center) A newer form of shingles vaccine reduced outbreaks of the painful rash among patients who were transplanted with their own stem cells, according to a study led by a Duke Health researcher and published today in JAMA. The vaccine appears to offer protection from one of the most common and painful side effects of cell therapy and shows promise for patients with immune-compromising conditions.
Condition: Herpes Zoster Intervention: Biological: PED-HZ/su Sponsor: GlaxoSmithKline Not yet recruiting
Children who have been vaccinated for chickenpox have a 78 percent lower risk of developing shingles than unvaccinated children, according to research.
Kids who were vaccinated against chickenpox had a 78% lower risk of developing shingles, the researchers said.
MONDAY, June 10, 2019 -- Shingles isn't usually considered a kids'disease, but children can get this painful condition. Fortunately, the chickenpox vaccine can also protect them against it, a new study finds. " The virus that causes chickenpox also...
Children vaccinated against chickenpox had a 78 percent lower rate of shingles than their unvaccinated peers.
Discussion: These two cases demonstrate that singles vaccination is not an absolute protection against varicella zoster virus–related acute retinal necrosis. However, such vaccination may reduce the severity of the acute retinal necrosis.
GlaxoSmithKline Plc said on Thursday its shingles vaccine had been approved for use in China in adults aged 50 and above.